Efficacy of Training Programme to Reduce Stress

Status Completed

Clinical Trial Summary

This study aims to reduce stress in mothers of children with autism in Saudi Arabia. The researcher has designed a training programme for mothers whose children are young and just in their early stage at the autism organisations they are attending. The programme will include stress reduction tips, behavioural modification strategies for children with autism, and financial resources available to parents (how they can access government funding). The study will have two parts. Part one involves conducting an experiment by dividing the participants into two groups, one group will receive the training and the other group will wait until the end of the study then they will also receive the same training. Both groups will fill questionnaire at the beginning of the study, then after the first group finishes training, and then again 6 weeks later. Part two of the study will involve interviewing mothers of the first group who attended the training session. They will be interviewed by the researcher asking them about their experience with the training programme and their suggestions for future improvements. Mothers will be given a training manual at the beginning of the training. Training involves attending five sessions, one of which is a face to face session at the autism organisation their children are attending and the other four sessions will be through a Smartphone application called whatsapp which is widely used in Saudi Arabia.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator)

Related Conditions & MeSH terms

Autism Spectrum Disorder
Autism Spectrum Disorder (ASD)
Child Development Disorders, Pervasive

Clinical Trial Details

NCT number	NCT02384486
Study type	Interventional
Source	University of Nottingham
Contact
Status	Completed
Phase	N/A
Start date	April 2015
Completion date	December 2015

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03715166` - Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder	Phase 3
Not yet recruiting	`NCT05182697` - SCI-210 in the Treatment of Children and Young Adults With AutismEvaluate the Safety, Tolerability and Efficacy of SCI-210 in Children With Autism Spectrum Disorder (ASD)	N/A
Completed	`NCT02803801` - Build Your Parenting Toolkit: Guiding Children to Become Flexible Thinkers	N/A
Recruiting	`NCT04376151` - Guided ACT and for Adults With ASD	N/A
Terminated	`NCT03715153` - Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder.	Phase 3
Terminated	`NCT01592773` - Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)	Phase 2
Withdrawn	`NCT01395953` - Double-blind Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders	Phase 2
Terminated	`NCT01248130` - Omega-3 Fatty Acids Monotherapy in Children and Adolescents With Autism Spectrum Disorders	Phase 2
Completed	`NCT04860986` - A Repeatability and Reproducibility Study of the EarliPoint™ Device
Active, not recruiting	`NCT04299464` - A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD)	Phase 2
Recruiting	`NCT03392870` - Evaluation of a Clinical Transitional Program in Autism	N/A
Completed	`NCT01592786` - An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)	Phase 2
Enrolling by invitation	`NCT05187377` - A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism	Phase 2
Completed	`NCT04631432` - Choice Switching and Autism
Recruiting	`NCT04578756` - Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder	Phase 3
Completed	`NCT02037022` - Pivotal Response Treatment Package for Young Children With Autism	N/A
Completed	`NCT01854346` - Social Skills Group Training ("KONTAKT") for Children and Adolescent With High-functioning Autism Spectrum Disorders	N/A
Active, not recruiting	`NCT04895215` - AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD)	Phase 2
Active, not recruiting	`NCT03426826` - The Gut-Brain Study	Phase 1
Completed	`NCT00614198` - ScanBrit Dietary Intervention in Autism	Phase 2